Protein homeostasis in chronic hemodialysis patients

被引:15
作者
Pupim, LB
Flakoll, PJ
Ikizler, TA
机构
[1] Iowa State Univ, Ctr Design Foods Improve Nutr, Ames, IA USA
[2] Vanderbilt Univ, Med Ctr, Div Nephrol, Dept Med, Nashville, TN 37232 USA
关键词
hemodialysis; catabolism; insulin; nutrition; metabolism;
D O I
10.1097/00075197-200401000-00014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Nutritional status is an important predictor of clinical outcome in chronic hemodialysis patients, as uremic malnutrition is strongly associated with an increased risk of death and hospitalization events. Decreased muscle mass is the most significant predictor of morbidity and mortality in these patients. Several factors that influence protein metabolism predispose chronic hemodialysis patients to increased catabolism and the loss of lean body mass. The purpose of this review is to discuss recent advances in the understanding of abnormalities in protein homeostasis in chronic hemodialysis patients. Recent findings It has long been suspected that the hemodialysis procedure is a net catabolic event. Recent studies have indeed shown that the hemodialysis procedure induces a net protein catabolic state at the whole-body level as well as in skeletal muscle. There is evidence to suggest that these undesirable effects are caused by decreased protein synthesis and increased proteolysis. The provision of nutrients, either in the form of intradialytic parenteral nutrition or oral feeding during hemodialysis, can adequately compensate the catabolic effects of the hemodialysis procedure. Whereas the mechanisms of these effects have not been studied in detail, changes in extracellular amino acid concentrations and certain anabolic hormones such as insulin are important mediators of these actions. Summary There is now indisputable evidence to suggest that the hemodialysis procedure leads to a highly catabolic state. Despite this, chronic hemodialysis patients can still achieve anabolism when given adequate protein supplementation to meet the metabolic requirements of hemodialysis, and when adequate insulin is present.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 49 条
[1]  
Anderstam B, 1996, J AM SOC NEPHROL, V7, P2453
[2]  
BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329
[3]  
BERGSTROM J, 1989, ADV EXP MED BIOL, V260, P1
[4]   Mechanisms of altered protein turnover in chronic diseases: a review of human kinetic studies [J].
Biolo, G ;
Antonione, R ;
Barazzoni, R ;
Zanetti, M ;
Guarnieri, G .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (01) :55-63
[5]   Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids [J].
Bohé, J ;
Low, JFA ;
Wolfe, RR ;
Rennie, MJ .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 532 (02) :575-579
[6]   NITROGEN-BALANCE DURING INTERMITTENT DIALYSIS THERAPY OF UREMIA [J].
BORAH, MF ;
SCHOENFELD, PY ;
GOTCH, FA ;
SARGENT, JA ;
WOLFSON, M ;
HUMPHREYS, MH .
KIDNEY INTERNATIONAL, 1978, 14 (05) :491-500
[7]   Inflammatory signals associated with hemodialysis [J].
Caglar, K ;
Peng, Y ;
Pupim, LB ;
Flakoll, PJ ;
Levenhagen, D ;
Hakim, RM ;
Ikizler, TA .
KIDNEY INTERNATIONAL, 2002, 62 (04) :1408-1416
[8]   CANADIAN HEMODIALYSIS MORBIDITY STUDY [J].
CHURCHILL, DN ;
TAYLOR, DW ;
COOK, RJ ;
LAPLANTE, P ;
BARRE, P ;
CARTIER, P ;
FAY, WP ;
GOLDSTEIN, MB ;
JINDAL, K ;
MANDIN, H ;
MCKENZIE, JK ;
MUIRHEAD, N ;
PARFREY, PS ;
POSEN, GA ;
SLAUGHTER, D ;
ULAN, RA ;
WERB, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) :214-234
[9]   UREA INDEX AND OTHER PREDICTORS OF HEMODIALYSIS PATIENT SURVIVAL [J].
COLLINS, AJ ;
MA, JZ ;
UMEN, A ;
KESHAVIAH, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :272-282
[10]  
Cranford W, 1998, Nephrol News Issues, V12, P33